# US 2019/0038459 A1 · Methods, systems, and devices for treating neuromas, fibromas, nerve entrapment, and/or pain associated therewith

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0038459 A1
- Document ID: US20190038459A1
- Status: Published application
- Kind: A1
- Application number: 16/132,205
- Filed: 2018-09-14
- Published: 2019-02-07
- Earliest claimed: 2013-03-15
- Assignees: MyoScience, Inc.
- Applicants: MyoScience, Inc.
- Inventors: Jwala Karnik; John Allison; Clint Carnell
- Web page: https://patentgrep.com/patent/US20190038459A1

## CPC

- A61F 7/12: Devices for heating or cooling internal body cavities
- A61B 18/02: by cooling, e.g. cryogenic techniques
- A61M 5/00: Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests (tube connectors, tube couplings, valves or branch units, specially adapted for medical use A61M39/00; containers specially adapted for medical or pharmaceutical purposes A61J1/00)
- A61N 1/403: {for thermotherapy, e.g. hyperthermia}
- A61B 2018/00041: {Heating, e.g. defrosting}
- A61B 2018/00434: {Neural system}
- A61B 2018/0293: {using an instrument interstitially inserted into the body, e.g. needle}
- A61B 2018/1425: {Needle}
- A61F 2007/0042: {Knee}
- A61F 2007/0087: {Hand-held applicators}
- A61F 2007/0285: {Local anaesthetic effect}
- A61M 2202/0484: Alcohol
- A61M 2210/086: Legs
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

A method in which a location is determined on the skin that is proximate to a sensory nerve that is associated with a painful condition. At least one needle of a cryogenic device is inserted into the location on the skin such that the needle is proximate to the sensory nerve. The device is activated such that the at least one needle creates a cooling zone about the sensory nerve, thereby eliminating or reducing severity of the painful condition.

## Claims

### Claim 1

A system for treating a neuroma in a limb of a patient, the system comprising:
a needle having a proximal end, a distal end, and a needle lumen therebetween, the needle configured for insertion proximate to the nerve;
a cooling fluid supply lumen extending distally within the needle lumen to a distal portion of the needle lumen;
a cooling fluid source couplable to the cooling fluid supply lumen to direct cooling fluid flow into the needle lumen so that liquid from the cooling flow vaporizes within the needle lumen to provide cooling to the nerve such that neuroma decreases in size and/or pain associated with the neuroma and experienced by the patient is reduced.

### Claim 2 (depends on 1)

The system of claim 1, wherein the cooling flow vaporizes within the needle lumen to provide a cryozone having a cross-sectional area between 14-40 mm2, the cryozone being defined by a 0° C. isotherm.

### Claim 3 (depends on 1)

The system of claim 1, wherein the cooling flow vaporizes within the needle lumen to provide a cryozone having a volume between 65-105 mm3, the cryozone being defined by a 0° C. isotherm.

### Claim 4 (depends on 1)

The system of claim 1, further comprising:
a heating element coupled with a proximal portion of the needle, the heating element configured to deliver heating phases to the skin of the patient; and
a processor configured to control the cooling fluid flow and the heating element in response to operator input, the processor configured to provide a treatment cycle in response to a treatment instruction, the treatment cycle comprising at least one heating phase and one cooling phase.

### Claim 5 (depends on 3)

The system of claim 3, wherein the processor is further configured to provide a degree of skin warmer throughout the treatment cycle.

### Claim 6 (depends on 5)

The system of claim 5, wherein the degree of skin warmer comprises 28-42° C. skin warmer throughout the treatment cycle.

### Claim 7 (depends on 3)

The system of claim 3, wherein the at least one heating phase comprises a pre-warm phase with the heating element before the at least one cooling phase.

### Claim 8 (depends on 6)

The system of claim 6, wherein the pre-warm phase has a duration of 8-12 seconds.

### Claim 9 (depends on 6)

The system of claim 6, wherein the at least one cooling phase has a duration of 20-65 seconds.

### Claim 10 (depends on 8)

The system of claim 8, wherein the at least one cooling phase has a duration of less than 40 seconds, and wherein the at least one cooling phase creates a cryozone having a cross-sectional area between 14-40 mm2, the cryozone being defined by a 0° C. isotherm.

### Claim 11 (depends on 8)

The system of claim 8, wherein the at least one cooling phase has a duration of less than 40 seconds, and wherein the at least one cooling phase creates a cryozone having a volume between 65-105 mm3, the cryozone being defined by a 0° C. isotherm.

### Claim 12 (depends on 8)

The system of claim 8, wherein the at least one heating phase further comprises a post-warm phase.

### Claim 13 (depends on 11)

The system of claim 11, wherein the post-warm phase has a duration of 12-18 seconds, and wherein the distal portion of the needle has a temperature of at least 0° C. at the end of the post-warm phase.

### Claim 14 (depends on 1)

The system of claim 1, wherein the needle comprises a length of 5-14 mm.

### Claim 15 (depends on 1)

The system of claim 1, wherein the processor is configured to provide an audio or visual alert at completion of a treatment cycle.
